의료 진단 분야 AI 시장 규모, 점유율, 성장 분석, 컴포넌트별, 최종사용자별, 모달리티별, 용도별, 지역별 - 산업 예측(2025-2032년)
AI in Medical Diagnostics Market Size, Share, and Growth Analysis, By Component (Software, Services), By End User (Hospitals, Diagnostic Imaging Centers), By Modality, By Application, By Region - Industry Forecast 2025-2032
상품코드:1758692
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 06월
페이지 정보:영문 194 Pages
라이선스 & 가격 (부가세 별도)
한글목차
의료 진단 분야 AI 세계 시장 규모는 2023년에 14억 달러로 평가되었고, 예측 기간(2025년-2032년) CAGR은 24.5%로, 2024년 17억 4,000만 달러에서 2032년까지는 100억 6,000만 달러로 성장할 전망입니다.
세계 의료 진단 분야 AI 시장은 질병의 조기 발견, 헬스케어 IT 시스템에 대한 AI의 통합, 진단 전문가 부족에 대한 수요 증가로 인해 크게 성장하고 있습니다. 세계 각국의 정부 및 의료 기관은 AI를 활용하여 임상적 의사결정을 강화하고 진단 프로세스를 간소화하기 위해 AI를 활용하고 있습니다. 2024년 5월 현재 영국 국민보건서비스(NHS)는 방사선과에 AI 툴을 도입하여 흉부 엑스레이 촬영 시간을 11시간에서 48시간 미만으로 대폭 단축하여 암 발견과 환자 분류를 개선하고 있습니다. 또한, 하이테크 기업과 학술 기관의 협력은 빠른 기술 혁신을 촉진하고, 이미지 분석, AI 기반 병리학 소프트웨어, 건강 예측 모델의 발전은 시장을 더욱 촉진하고 있습니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
주요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 분석
기술 분석
사례 연구
의료 진단 분야 AI 시장 규모 : 컴포넌트별·CAGR(2025년-2032년)
시장 개요
소프트웨어
이미징 소프트웨어
예측 분석 소프트웨어
진단 소프트웨어
서비스
하드웨어
프로세서
마이크로프로세서
그래픽 프로세서
FPGA
ASIC
메모리
네트워크
어댑터
스위치
상호 접속
의료 진단 분야 AI 시장 규모 : 최종사용자별·CAGR(2025년-2032년)
시장 개요
병원
진단영상센터
진단실험실
기타 최종사용자
의료 진단 분야 AI 시장 규모 : 모달리티별·CAGR(2025년-2032년)
시장 개요
영상 진단 장비
컴퓨터 단층촬영
X선
자기공명영상(MRI)
초음파
맘모그래피
기타 영상 진단법
진단 모달리티
면역측정
임상화학
혈액학
미생물학
기타 진단 모달리티
의료 진단 분야 AI 시장 규모 : 용도별·CAGR(2025년-2032년)
시장 개요
In Vivo 진단 용도
방사선과
종양학
심장병학
신경학
산부인과
안과
기타 In Vivo 용도
In Vitro 진단 용도
감염증
내분비학
자가면역 검사
혈액검사와 응고 검사
기타 In Vitro 용도
의료 진단 분야 AI 시장 규모·CAGR(2025년-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
매출 전년대비 비교(2022년-2024년)
주요 기업 개요
Microsoft
Nvidia Corporation
Merative
Google(Alphabet, Inc.)
Intel Corporation
Siemens Healthineers Ag
GE Healthcare
Advanced Micro Devices, Inc.
Koninklijke Philips N.V.
Digital Diagnostics, Inc.
Informai
Heartflow, Inc.
Enlitic, Inc.
Butterfly Network, Inc.
Nano-X Imaging Ltd.
Viz.Ai, Inc.
Quibim
Qure.Ai
Therapixel
Aidoc
결론과 제안
LSH
영문 목차
영문목차
Global AI in Medical Diagnostics Market size was valued at USD 1.4 billion in 2023 and is poised to grow from USD 1.74 billion in 2024 to USD 10.06 billion by 2032, growing at a CAGR of 24.5% during the forecast period (2025-2032).
The global AI in medical diagnostics market is experiencing significant growth, driven by the increasing demand for early disease detection, integration of AI into healthcare IT systems, and the shortage of diagnostic professionals. Governments and healthcare organizations worldwide are leveraging AI to enhance clinical decision-making and streamline diagnostic processes. A notable example is the UK's National Health Service (NHS), which, as of May 2024, deployed AI tools in radiology departments, drastically reducing chest X-ray turnaround times from 11 days to under 48 hours, thereby improving cancer detection and patient triaging. Additionally, collaboration among tech companies and academic institutions is fostering rapid innovation, further propelling the market, with advancements in imaging analytics, AI-powered pathology software, and predictive health models.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global AI in Medical Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global AI in Medical Diagnostics Market Segments Analysis
Global AI in Medical Diagnostics Market is segmented by Component, End User, Modality, Application and region. Based on Component, the market is segmented into Software, Services and Hardware. Based on End User, the market is segmented into Hospitals, Diagnostic Imaging Centers, Diagnostic Laboratories and Other End Users. Based on Modality, the market is segmented into Imaging Modalities and Diagnostics Modalities. Based on Application, the market is segmented into In Vivo Diagnostics Applications and In Vitro Diagnostics Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global AI in Medical Diagnostics Market
The global market for AI in medical diagnostics is rapidly evolving, driven by significant advancements in technologies such as deep learning, computer vision, and natural language processing. These innovations enable AI systems to effectively analyze and interpret intricate medical data, including imaging scans, pathology slides, and genetic information, with remarkable accuracy. As a result, the incorporation of AI-supported diagnostic tools is increasingly vital for healthcare professionals who seek to elevate the quality of care through enhanced decision-making capabilities and improved patient outcomes. This ongoing trend highlights the pivotal role that AI plays in transforming the landscape of medical diagnostics.
Restraints in the Global AI in Medical Diagnostics Market
The Global AI in Medical Diagnostics market faces significant constraints due to the substantial initial costs associated with AI implementations. These expenses encompass various elements such as infrastructure, software licenses, integration with existing hospital systems, and essential workforce training. Such financial burdens can be particularly daunting for small and medium-sized hospitals and diagnostic laboratories, especially in developing regions where budget limitations are a common issue. As a result, the high entry costs may hinder the adoption of AI technologies in medical diagnostics, ultimately impacting the overall growth and advancement of the market in these areas.
Market Trends of the Global AI in Medical Diagnostics Market
The Global AI in Medical Diagnostics market is witnessing a significant expansion, particularly in radiology and pathology, where advanced deep learning algorithms are revolutionizing disease detection. By 2025, a notable percentage of radiology departments in North America and Europe are expected to adopt AI-driven tools like Aidoc and PathAI, enhancing diagnostic accuracy for conditions such as cancers and brain hemorrhages while substantially reducing turnaround times. This trend underscores a growing reliance on AI technology in clinical settings, emphasizing its critical role in improving patient outcomes and facilitating differential diagnoses. Overall, the integration of AI into these fields signifies a transformative shift in healthcare delivery.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Technology Analysis
Case Studies
Global AI in Medical Diagnostics Market Size by Component & CAGR (2025-2032)
Market Overview
Software
Imaging Software
Predictive Analysis Software
Diagnostic Software
Services
Hardware
Processors
MPU
GPU
FPGA
ASIC
Memory
Networks
Adapter
Switch
Interconnect
Global AI in Medical Diagnostics Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals
Diagnostic Imaging Centers
Diagnostic Laboratories
Other End Users
Global AI in Medical Diagnostics Market Size by Modality & CAGR (2025-2032)
Market Overview
Imaging Modalities
Computed Tomography
X-Ray
Magnetic Resonance Imaging
Ultrasound
Mammography
Other Imaging Modalities
Diagnostics Modalities
Immunoassay
Clinical Chemistry
Hematology
Microbiology
Other Diagnostic Modalities
Global AI in Medical Diagnostics Market Size by Application & CAGR (2025-2032)
Market Overview
In Vivo Diagnostics Applications
Radiology
Oncology
Cardiology
Neurology
Obstetrics/Gynecology
Ophthalmology
Other In Vivo Applications
In Vitro Diagnostics Applications
Infectious Diseases
Endocrinology
Autoimmune Testing
Blood Screening and Coagulation Testing
Other In Vitro Applications
Global AI in Medical Diagnostics Market Size & CAGR (2025-2032)
North America (Component, End User, Modality, Application)
US
Canada
Europe (Component, End User, Modality, Application)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Component, End User, Modality, Application)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Component, End User, Modality, Application)
Brazil
Rest of Latin America
Middle East & Africa (Component, End User, Modality, Application)
